Consolidation Chemotherapy for Adults With AML in First Remission: Is There a Best Choice?

被引：10

作者：

Stone, Richard M. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 17期

关键词：

ACUTE MYELOID-LEUKEMIA; HIGH-DOSE CYTARABINE; GROUP-B; THERAPY; MUTATIONS; CANCER; INTENSIFICATION; YOUNGER; AGE;

D O I：

10.1200/JCO.2013.48.6886

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2067 / 2069

页数：3

共 22 条

[1] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [J].

Bishop, JF ;

Matthews, JP ;

Young, GA ;

Szer, J ;

Gillett, A ;

Joshua, D ;

Bradstock, K ;

Enno, A ;

Wolf, MM ;

Fox, R ;

Cobcroft, R ;

Herrmann, R ;

VanDerWeyden, M ;

Lowenthal, RM ;

Page, F ;

Garson, OM ;

Juneja, S .

BLOOD, 1996, 87 (05) :1710-1717

[2]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[3] Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial [J].

Brune, Mats ;

Castaigne, Sylvie ;

Catalano, John ;

Gehlsen, Kurt ;

Ho, Anthony D. ;

Hofmann, Wolf-Karsten ;

Hogge, Donna E. ;

Nilsson, Bo ;

Or, Reuven ;

Romero, Ana I. ;

Rowe, Jacob M. ;

Simonsson, Bengt ;

Spearing, Ruth ;

Stadtmauer, Edward A. ;

Szer, Jeff ;

Wallhult, Elisabeth ;

Hellstrand, Kristoffer .

BLOOD, 2006, 108 (01) :88-96

[4] Therapeutic Advances in Acute Myeloid Leukemia [J].

Burnett, Alan ;

Wetzler, Meir ;

Loewenberg, Bob .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) :487-494

[5] Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia [J].

Buyse, Marc ;

Squifflet, Pierre ;

Lange, Beverly J. ;

Alonzo, Todd A. ;

Larson, Richard A. ;

Kolitz, Jonathan E. ;

George, Stephen L. ;

Bloomfield, Clara D. ;

Castaigne, Sylvie ;

Chevret, Sylvie ;

Blaise, Didier ;

Maraninchi, Dominique ;

Lucchesi, Kathryn J. ;

Burzykowski, Tomasz .

BLOOD, 2011, 117 (26) :7007-7013

[6]

CASSILETH PA, 1984, BLOOD, V63, P843

[7] CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics:: Prognostic relevance and analysis of cooperating mutations [J].

Fröhling, S ;

Schlenk, RE ;

Stolze, I ;

Bihlmayr, J ;

Benner, A ;

Kreitmeier, S ;

Tobis, K ;

Döhner, H ;

Döhner, K .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :624-633

[8] FLT3 as a therapeutic target in AML: still challenging after all these years [J].

Kindler, Thomas ;

Lipka, Daniel B. ;

Fischer, Thomas .

BLOOD, 2010, 116 (24) :5089-5102

[9] P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808 [J].

Kolitz, Jonathan E. ;

George, Stephen L. ;

Marcucci, Guido ;

Vij, Ravi ;

Powell, Bayard L. ;

Allen, Steven L. ;

DeAngelo, Daniel J. ;

Shea, Thomas C. ;

Stock, Wendy ;

Baer, Maria R. ;

Hars, Vera ;

Maharry, Kati ;

Hoke, Eva ;

Vardiman, James W. ;

Bloomfield, Clara D. ;

Larson, Richard A. .

BLOOD, 2010, 116 (09) :1413-1421

[10]

Löwenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222

← 1 2 3 →